Blog

Photo from ESTRO/LinkedIn

Aug 26, 2024, 06:20

SBRT in Prostate Cancer at ESTRO24

European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:

“Five-year outcomes from the hypo-FLAME trial, acute toxicity results from the PACE-C trial, and key findings from the STORM trial were revealed at ESTRO24. Learn how SBRT is advancing treatment and improving outcomes in prostate cancer.”

Read further.
Source: ESTRO/LinkedIn

More posts featuring ESTRO24 on oncodaily.com

cancer David Pasquier ESTRO ESTRO24 European SocieTy for Radiotherapy and Oncology hypo-FLAME trial OncoDaily Oncology PACE-C trial prostate cancer radiation oncology SBRT SBRT in prostate cancer STORM trial

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage